Accuretic: profile and news

Pfizer Fourth-Quarter and Full-Year 2005 Financial Results Reflect ... Jan 19, 2006
...$13,101 (11) $44,284 $46,133 (4) Celebrex 472 1,008 (53) 1,730 3,302 (48) Bextra (2) 417 * (61) 1,286 * Dynastat 8 14 (44) 34 46 (25) Accupril/Accuretic 44 165 ... - PR Newswire (press release),

Pfizer Inc Third-Quarter 2005 Performance Report Oct 20, 2005
...$11,288 (7) $32,629 $33,033 (1) Celebrex 446 797 (44) 1,258 2,294 (45) Bextra (73) 324 * (59) 869 * Dynastat 7 13 (51) 26 31 (16) Accupril/Accuretic 77 157 (51 ... - PR Newswire (press release),

Pfizer Inc Second-Quarter 2005 Performance Report Jul 20, 2005
2,858 2,363 21 1,680 1,313 28 1,178 1,050 12 NORVASC 1,156 1,032 12 523 412 27 633 620 2 CARDURA 155 161 (4) 1 1 (6) 154 160 (4) ACCUPRIL/ ACCURETIC 73 153 (53 ... - Yahoo News (press release)

Nine major Puerto Rico drug manufacturers report $24.3 billion in ... Jun 3, 2005
Three more Pfizer medicines, Neurontin (-73.9%), Diflucan (-54.6%), and Accupril / Accuretic (-47.6%) showed considerable losses during this same period ... - Puerto Rico Herald,

Mylan gets FDA OK for generic Accuretic Apr 1, 2005
Friday that its pharmaceutical unit gained approval from the Food and Drug Administration to market a generic version of Pfizer Inc.'s Accuretic high blood ... - BusinessWeek

Pfizer Inc First-Quarter 2005 Performance Report Apr 19, 2005
3,075 2,497 23 1,913 1,573 22 1,162 924 26 NORVASC 1,175 1,141 3 540 489 11 635 652 (3) CARDURA 153 148 4 1 3 (44) 152 145 4 ACCUPRIL/ ACCURETIC 100 191 (47 ... - PR Newswire

Mylan Receives Approval for Quinapril Hydrochloride and ... Apr 1, 2005
Quinapril Hydrochloride and Hydrochlorothiazide Tablets are the generic version of Pfizer Pharmaceuticals’ Accuretic(R) Tablets. ... - mysan.de (Pressemitteilung)

Ranbaxy to appeal against US patent ruling Mar 30, 2005
Accupril and related blood-pressure drug Accuretic generated $665 million in worldwide sales last year for Pfizer. The case is Pfizer Inc. ... - Financial Express

Business news briefs: 4/2/05 Apr 1, 2005
Mylan Laboratories said the US Food and Drug Administration approved its generic version of Accuretic, the Pfizer drug that is used to treat high blood ... - Pittsburgh Post Gazette

Ranbaxy to appeal against US court order Mar 30, 2005
Accupril and the related Accuretic contributed about $665 million to the Pfizer's sales last year, with a major portion of the revenues coming from Accupril. ... - Sify

Biotech Stocks Apr 1, 2005
The generic drugmaker said it had won FDA approval to market a generic version of Pfizer's hypertension drug Accuretic, also known as quinapril. - MarketWatch

Mylan Receives Approval for Quinapril Hydrochloride and ... Apr 1, 2005
Quinapril Hydrochloride and Hydrochlorothiazide Tablets are the generic version of Pfizer Pharmaceuticals' Accuretic® Tablets. Mylan Laboratories Inc. ... - Yahoo News

BCBSNC Launches New Prescription Drug Savings Initiative Feb 17, 2005
HCTZ (generic Zestoretic, Prinzide) metoprolol/HCTZ (generic Lopressor HCT) propranolol/HCTZ (generic Inderide) quinapril/HCTZ (generic Accuretic) ORAL AGENTS ... - PR Newswire (press release)